Total Payments
$17,878
2024 Payments
$2,281
Companies
58
Transactions
844
Medicare Patients
11,212
Medicare Billing
$722,793
Payment Breakdown by Category
Food & Beverage$16,458 (92.1%)
Education$1,419 (7.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,458 | 821 | 92.1% |
| Education | $1,419 | 23 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $3,019 | 169 | $0 (2024) |
| Astellas Pharma US Inc | $2,662 | 129 | $0 (2024) |
| Janssen Biotech, Inc. | $1,807 | 98 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $815.35 | 31 | $0 (2024) |
| NeoTract Inc. | $789.51 | 10 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $678.52 | 40 | $0 (2024) |
| Blue Earth Diagnostics Limited | $619.16 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $550.07 | 31 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $503.71 | 23 | $0 (2024) |
| PFIZER INC. | $488.53 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,281 | 87 | Dendreon Pharmaceuticals LLC ($662.47) |
| 2023 | $2,538 | 104 | Myriad Genetic Laboratories, Inc. ($528.55) |
| 2022 | $2,997 | 148 | Dendreon Pharmaceuticals LLC ($735.89) |
| 2021 | $2,181 | 133 | Dendreon Pharmaceuticals LLC ($498.60) |
| 2020 | $1,210 | 61 | Astellas Pharma US Inc ($316.78) |
| 2019 | $1,523 | 86 | Astellas Pharma US Inc ($659.46) |
| 2018 | $2,578 | 111 | Astellas Pharma US Inc ($551.02) |
| 2017 | $2,570 | 114 | Astellas Pharma US Inc ($683.78) |
All Payment Transactions
844 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Oncology | ||||||
| 11/14/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/13/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/07/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diagnostic Imaging | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: UROLOGY | ||||||
| 10/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/30/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: HORMONE THERAPY | ||||||
| 09/24/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $143.43 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/18/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/17/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,429 | 5,922 | $409,723 | $125,022 |
| 2022 | 39 | 2,883 | 7,032 | $528,827 | $173,368 |
| 2021 | 40 | 3,116 | 8,823 | $634,917 | $251,848 |
| 2020 | 43 | 2,784 | 23,351 | $457,719 | $172,555 |
Total Patients
11,212
Total Services
45,128
Medicare Billing
$722,793
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 367 | 490 | $60,865 | $28,805 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 238 | $49,766 | $20,420 | 41.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 112 | $71,008 | $15,239 | 21.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 86 | $41,194 | $14,794 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $26,970 | $9,235 | 34.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 222 | 301 | $20,333 | $5,408 | 26.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 22 | 22 | $15,906 | $3,830 | 24.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 64 | 70 | $15,330 | $3,726 | 24.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 425 | 712 | $13,450 | $3,599 | 26.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 18 | 18 | $16,110 | $3,526 | 21.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 23 | 23 | $6,417 | $2,405 | 37.5% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 47 | 88 | $8,448 | $2,226 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $3,750 | $1,987 | 53.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 153 | 232 | $8,120 | $1,658 | 20.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,243 | $1,367 | 32.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 17 | 18 | $4,500 | $1,320 | 29.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 319 | 488 | $3,884 | $1,066 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 32 | $2,400 | $1,033 | 43.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 38 | $3,344 | $977.74 | 29.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 182 | 277 | $3,292 | $861.47 | 26.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 70 | $4,130 | $652.20 | 15.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 33 | 34 | $1,734 | $450.82 | 26.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 23 | 2,400 | $24,000 | $281.46 | 1.2% |
| 82565 | Blood creatinine level | Office | 2023 | 21 | 21 | $399.00 | $105.42 | 26.4% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 26 | 26 | $130.00 | $48.18 | 37.1% |
About Dr. Scott Baker, MD
Dr. Scott Baker, MD is a Urology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861504318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Baker, MD has received a total of $17,878 in payments from pharmaceutical and medical device companies, with $2,281 received in 2024. These payments were reported across 844 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($16,458).
As a Medicare-enrolled provider, Baker has provided services to 11,212 Medicare beneficiaries, totaling 45,128 services with total Medicare billing of $722,793. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Raleigh, NC
- Active Since 08/31/2006
- Last Updated 01/07/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1861504318
Products in Payments
- PROVENGE (Drug) $3,237
- ERLEADA (Drug) $1,344
- MYRBETRIQ (Drug) $943.70
- XTANDI (Drug) $865.27
- GEMTESA (Drug) $707.77
- XIAFLEX (Biological) $693.57
- KEYTRUDA (Biological) $521.68
- Axumin (Drug) $519.18
- TITAN (Device) $469.87
- Myrbetriq (Drug) $456.92
- ZYTIGA (Drug) $445.79
- UroLift (Device) $394.89
- Urolift - UL400 (Device) $394.62
- BOTOX (Biological) $318.75
- PROLARIS (Device) $313.96
- ORGOVYX (Drug) $309.40
- Xofigo (Drug) $296.09
- CAMCEVI (Drug) $293.81
- MYRISK (Device) $271.70
- JELMYTO (Drug) $253.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Raleigh
Dr. Mark Jalkut, Md, MD
Urology — Payments: $124,401
Urology $124,401
Dr. Andrew Chang, Md, MD
Urology — Payments: $14,872
Urology $14,872
Dr. Joseph Neighbors, M.d, M.D
Urology — Payments: $12,226
Urology $12,226
Merry Ma
Urology — Payments: $12,107
Urology $12,107
Brian Bennett, M.d, M.D
Urology — Payments: $11,989
Urology $11,989
Dr. Stephen Shaban, Md, MD
Urology — Payments: $11,877
Urology $11,877